Pharmaceutical

Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).

Nov 29, 2024 - 06:00
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).
Read the original article

Tags:

Previous Article

Trump agency nominations show pharma industry as divided as US

Next Article

Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Gr...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Value-based payments are making it harder to see your primary care doctor on short notice

Opinion: Value-based payments are making it harder to s...

Sep 20, 2023

STAT+: Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts

STAT+: Jay Bradner, former Novartis research leader, to...

Dec 15, 2023

STAT+: Cano Health’s downfall offers a warning for Medicare Advantage

STAT+: Cano Health’s downfall offers a warning for Medi...

Feb 5, 2024